|
|
Title | Creator | Date |
26 |
|
The Usefulness of Anti-acetylcholine Receptor Binding Antibody Testing in Diagnosing Ocular Myasthenia Gravis | In Young Chung, MBBS Hons, BBMED; Shivanand J. Sheth, MBBS, MS (Ophthal), FICO, FAICO, FRANZCO; Kristen K. Wells, MD, FRANZCO; Thomas G. Campbell, MBBS, DPhil | 2021-12 |
27 |
|
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis | Sean M. Gratton, MD; Angela M. Herro, MD; William J. Feuer, MS; Byron L. Lam, MD | 2016-03 |
28 |
|
The edrophonium-hess screen test in the diagnosis of ocular myasthenia gravis. | | |
29 |
|
Involvement of Ocular Muscles in Patients With Myasthenia Gravis With Nonocular Onset | L. Lei; Z. Fan; S. Su; M. Xu; H. Chen; W. Zhu; Q. Luan; Y. Da | 2022-03 |
30 |
|
The sleep test for myasthenia gravis. A safe alternative to Tensilon. | Odel, J.G.; Winterkorn, J.M.; Behrens, M.M. | |
31 |
|
Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia | Robyn M. Rautenbach, MSc; Komala Pillay, MBChB; Anthony D. N. Murray, MBChB; Jeannine M. Heckmann, PhD | 2017-12 |
32 |
|
Safety of Prednisone for Ocular Myasthenia Gravis | Beau Bruce, MD, PhD, Emory University; Mark J. Kupersmith, MD, Mount Sinai | |
33 |
|
Comitant Ocular Deviation in Myasthenia Gravis | Tiffany Pike-Lee, MD; Jeremy Hill, MD; Jianbo Li, PhD; Gregory S. Kosmorsky, DO; Yuebing Li, MD, PhD | 2021-12 |
34 |
|
Lambert-Eaton Myasthenia Syndrome Initial Presentation Mimicking Myasthenia Gravis | S. Y. Uhm; H. Nguyen; K. P. Kanakia; J. E. Carter | 2023-06 |
35 |
|
Variable Ptosis after Botulinum Toxin Type A Injection with Positive Ice Test Mimicking Ocular Myasthenia Gravis | Alaraj, Ahmad M; Oystreck, Darren T; Bosley, Thomas M | |
36 |
|
Immune Checkpoint Inhibitor-Induced Ptosis in a Patient With Prostate Cancer | Katherine J. Williams; Richard C. Allen | 2021-03 |
37 |
|
Ocular Myasthenia Gravis Associated With Thymic Amyloidosis | Kristin O. Chapman, MD; Debra M. Beneck, MD; Marc J. Dinkin, MD | 2016-03 |
38 |
|
Ocular Myasthenia Gravis: Toward a Risk of Generalization Score and Sample Size Calculation for a Randomized Controlled Trial of Disease Modification | Sui H. Wong, MD, MRCP; Aviva Petrie, CStat; Gordon T. Plant, FRCP, FRCOphth | 2016-09 |
39 |
|
Clinical and subclinical oculomotor findings in the Eaton-Lambert syndrome. | Crucigar, M.P.; Brown, B.; Denys, E.H.; Magoon, E.; Wasson, P.J.; Newman, N.M.; Scott, A.B. | |
40 |
|
Mitochondrial Ophthalmoplegia with Fatigable Weakness and Elevated Acetylcholine Receptor Antibody | Behbehani, R; Sharfuddin, K; Anim, JT | |
41 |
|
Myasthenia Gravis Associated With Orbital Marginal Zone Lymphoma | Shu Feng; Ryan E. Dodge 3rd; Courtney E. Francis | 2019-06 |
42 |
|
Myasthenia gravis and Charcot-Marie-Tooth disease. | J. Lawton Smith, Professor Emeritus of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine | |
43 |
|
Literature abstracts. | | |
44 |
|
Literature abstracts. | | |
45 |
|
Lid Nystagmus as a Sign of Intrinsic Midbrain Disease | Brodsky, MC; Boop, FA | |
46 |
|
Myasthenia gravis-like syndrome induced by topical ophthalmic preparations. A case report. | Meyer, D.; Hamilton, R.C.; Gimbel, H.V. | |
47 |
|
Autoimmune Acquired Rippling Muscle Disease and Myasthenia Gravis | Dane A Breker; Ann A Little; Jonathan D Trobe | |
48 |
|
Atrophy of Bilateral Extraocular Muscles | Okamoto, K; Ito, J; Tokiguchi, S; Furusawa, T | |
49 |
|
Letters to the Editor | | |
50 |
|
Validity of Forced Eyelid Closure Test: A Novel Clinical Screening Test for Ocular Myasthenia Gravis. | Supanut Apinyawasisuk; Xinkai Zhou; Jack J. Tian; Giancarlo A. Garcia; Rustum Karanjia; Alfredo A. Sadun | 2017-09 |